Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2026-02-18 @ 11:26 PM
Study NCT ID:
NCT02906059
Status:
COMPLETED
Last Update Posted:
2020-10-12
First Post:
2016-09-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer
Sponsor:
NYU Langone Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09
Start Date Type:
None
Primary Completion Date:
2020-03-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-12
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-09
First Submit QC Date:
None
Study First Post Date:
2016-09-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-08
Last Update Post Date:
2020-10-12
Last Update Post Date Type:
ACTUAL